Evidence map›Paper›PMID 40626958›Full record

ReviewAngewandte Chemie (International ed. in English)2025

Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis.

Samuel J Paravizzini, Linda M Haugaard-Kedström, Craig A Hutton, John A Karas

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Late-stage generation ofNature communications · 2026
    Article
  2. Article
  3. Article
  4. Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis.Angewandte Chemie (International ed. in English) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samuel J ParavizziniSchool of Chemistry, The University of Melbourne, Grattan Street, Parkville, Victoria, 3010, Australia.ORCID 0009-0001-0798-4255
Linda M Haugaard-KedströmPolyPeptide Laboratories (Sweden) AB, Limhamnsvägen 108, PO Box 30089, Limhamn, 20061, Sweden.ORCID 0000-0003-0113-6535
Craig A HuttonSchool of Chemistry, The University of Melbourne, Grattan Street, Parkville, Victoria, 3010, Australia.ORCID 0000-0002-2353-9258
John A KarasSchool of Chemistry, The University of Melbourne, Grattan Street, Parkville, Victoria, 3010, Australia.ORCID 0000-0002-3800-5152

Funding

Australian Research Council (ARC) Discovery Early Career Researcher Award DE220101329
6 · The paper itself

Abstract

Solid-phase peptide synthesis has become an indispensable technique for the routine preparation of linear peptides of up to approximately 40 amino acids in length. However, the solid-phase approach is still hampered by chain insolubility and aggregation, which reduces synthetic yields. Moreover, many of the deletion impurities that can form are often chromatographically inseparable from the target sequence, which diminishes final product purity. The use of backbone N-protecting groups can ameliorate this synthetic inefficiency by increasing peptide chain solubility and suppressing aggregation. Backbone protection is also useful for promoting peptide macrocyclization, suppressing common side reactions in peptide chemistry, and improving solution-phase handling. Commercially available precursors containing benzyl-based groups and pseudoprolines have found widespread use, in academic laboratories and industry. A range of other strategies have also been investigated in a bid to increase the utility of backbone protecting groups and to develop more efficient methods for their introduction and removal. This review provides a comprehensive account of the state of the art, and includes detailed synthetic methods relating to the use of backbone protection, and its application to "difficult" peptides and proteins of biological significance. The strengths and weaknesses of each approach are analyzed, and a commentary on future directions is provided.

Indexed as

PeptidesProteinsSolid-Phase Synthesis TechniquesPeptidesProteinsAmidesChemical protein synthesisPeptidesProtecting groupsSolid‐phase peptide synthesis

Identifiers

PMID40626958
PMCPMC12338413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.